3PBIOVIAN Animal Health - Biotech Spain

Advancing Animal Health Through Innovative Biologics

Animals play an essential role in our lives, whether as companions or as vital sources of food and resources. At 3PBIOVIAN, they harness their expertise in recombinant protein biologics and advanced therapies to successfully develop and manufacture next-generation solutions for animal health. As a long-term strategic partner for animal health innovators, they e help transform cutting edge research into commercially viable therapies that improve the lives of animals worldwide.

Proven CDMO Experience in Veterinary Vaccines and Biological Therapies

3PBIOVIAN has a proven track record in the development and manufacturing of animal health vaccines. They support veterinary vaccine programs at every stage, from cell line and process development through scale-up and commercial manufacturing.

They routinely manufacture GMP batches for commercial veterinary products, ensuring consistent quality, reliable supply, and regulatory compliance.

Dedicated CDMO Services for Veterinary Biologics

They understand the technical, regulatory, and commercial complexities of veterinary products and offer tailored services to meet their clients’ specific needs.

Whether you are developing, novel vaccines, recombinant proteins, or monoclonal antibodies, they provide the speed, quality, robustness, and scalability that are essential to efficiently advance from preclinical development to GMP production and routine commercial manufacturing.

Your Strategic Manufacturing Partner for Animal Health

They collaborate with a diverse range of animal health organizations, including:

Startups developing innovative vaccine and biologic platforms
Established biotech firms advancing antibody-based therapies for companion and production animals
Global pharmaceutical companies outsourcing their animal health portfolios requiring microbial and mammalian manufacturing
Academic and veterinary institutions requiring non-GMP and GMP material for pre-clinical and clinical programs

Their role extends beyond development— they are a long-term partner committed to delivering sustained value as the program progresses to dependable commercial supply.

GMP Biologics Manufacturing for Animal Health

Their development and manufacturing capabilities span multiple biologic modalities and platforms, including:

Recombinant protein and antibodies expressed in microbial and mammalian systems
Plasmid DNA
Viral vectors (adenovirus and AAV)
Advanced biologic and cell-based therapies

With a wide range of bioreactor scales and flexible manufacturing configurations, they ensure a smooth transition from development stages to clinical and commercial production.

Manufacturing

Capacity

Mammalian (single-use bioreactors): 50 L | 200 L | 400 L | 2,000 L

Microbial (stainless-steel bioreactors): 10 L | 100 L | 200 L | 500 L | 1,000 L | 3,000 L

Viral vector manufacturing:

Adherent systems: up to 500 m²
Suspension systems: 10 L to 200 L

Plasmid DNA (stainless steel): 20 L | 40 L | 200 L

Why Animal Health Companies Partner with 3PBIOVIAN

Animal health companies choose 3PBIOVIAN because they offer:

A demonstrated track record in animal health biopharmaceutical development and commercial manufacturing
Seamless transition from process development and tech transfer to scale-up and large-scale manufacturing
Flexible infrastructure tailored to support commercial manufacturing needs
A flexible and cost-conscious CDMO model designed to align with the animal health market

Whether you are launching a new veterinary therapeutic or vaccine or are seeking a dependable long-term manufacturing partner, 3PBIOVIAN offers comprehensive support for your program from development to sustained market supply.

3PBIOVIAN — your trusted partner in delivering veterinary vaccines and biologic therapies, from sequence to market.